Introduction
During the last decade, clonal immunoglobulin (Ig) and T cell receptor (TCR) gene rearrangements have been successfully applied as PCR targets for detection of low frequencies of leukemic cells in order to assess the level of minimal residual disease (MRD) during and after cytotoxic treatment. The clinical relevance of MRD detection in acute lymphoblastic leukemia (ALL) was demonstrated by many retrospective studies and three large prospective studies, [1] [2] [3] two of which used Ig and TCR gene rearrangements as clone-specific PCR targets.
regions of Ig/TCR gene rearrangements is the instability of these PCR targets over time, owing to continuing and secondary rearrangements throughout the disease course. 4, 6 The chance of losing a PCR-target during follow-up and therefore the likelihood of false-negative MRD results is increased when subclones are already present at diagnosis. 7 Oligoclonality at diagnosis in the Ig heavy-chain (IGH) gene occurs in 30-40% of precursor-B-ALL, 4, 8 whereas it seems to be less frequent for TCR delta (TCRD) and gamma (TCRG). However, when only the group of patients having these cross-lineage TCRG or TCRD gene rearrangements are taken into account, the frequency of oligoclonality is comparable to that of IGH gene rearrangements. 9 Ongoing rearrangements are most frequently observed for IGH gene rearrangements and incomplete TCRD gene rearrangements. 7, [10] [11] [12] [13] In the IGH gene this generally concerns V H to D H -J H rearrangements and V H replacements. 7, [10] [11] [12] [13] Instability of the TCRD locus usually affects V␦2-D␦3 or D␦2-D␦3 gene rearrangements, probably by subsequent joining to J␣ gene segments. [14] [15] [16] IGH, TCRD, and TCRG gene rearrangements are commonly used as PCR targets for MRD detection in precursor-B-ALL, but also Ig light chain gene rearrangements can be used. Rearrangements of Ig lambda (IGL) genes are found in ෂ20% of precursor-B-ALL, 17 whereas Ig kappa (IGK) gene rearrangements occur in ෂ60% of cases. 18 IGK gene rearrangements in childhood precursor-B-ALL predominantly concern deletional rearrangements involving the kappa deleting element (Kde), which are found on one or both alleles in ෂ50% of precursor-B-ALL. 18, 19 The recombination signal sequence (RSS) of Kde is located approximately 24 kb downstream of the C gene segment and can rearrange to V gene segments, resulting in V-Kde rearrangements (deletion of J-C), or to the RSS located in the intron between the J and C gene segments, resulting in intron-Kde rearrangements (deletion of C). 19 The junctional region diversity of the IGK-Kde rearrangements in precursor-B-ALL is relatively large: mean insertion of 4.7 nucleotides and mean deletion of 9.5 nucleotides. 20 The frequency and the relatively large junctional regions make IGKKde rearrangements interesting PCR targets for MRD detection in precursor-B-ALL. Furthermore, unlike for the majority of IGH, TCRD, and TCRG gene rearrangements, IGK-Kde rearrangements cannot easily be replaced by continuing or secondary rearrangement processes, due to the absence of an RSS downstream of Kde. Therefore, they can be considered as end-stage rearrangements. In a previous study, 11 out of 12 IGK-Kde rearrangements were indeed found to be stable between diagnosis and relapse. 2 Recent clinical MRD studies in childhood ALL have shown that it is important to precisely determine the level of MRD for discrimination between low-risk, intermediate-risk, and high-risk patients. 
Materials and methods

Cell samples
Bone marrow (BM) and/or peripheral blood (PB) samples were obtained at diagnosis from 77 children with precursor-B-ALL (0-15 years). These patients were selected for the availability of sufficient cell material for investigation and for the presence of Southern blot-detectable IGK-Kde rearrangements.
18,20 BM samples were also obtained at relapse in 21 of the 77 children. From eight of the 77 children (four patients with a relapse and four patients in complete remission (CR)), several BM samples obtained during follow-up were also studied.
Mononuclear cells (MNC) were isolated from BM or PB samples by Ficoll-Paque separation (density 1.077 g/cm 3 ; Pharmacia, Uppsala, Sweden). MNC were either directly used for DNA isolation or viably frozen and stored in liquid nitrogen. DNA was isolated from fresh or frozen cells as described previously. 26, 27 Southern blot analysis DNA (ෂ15 g) was digested with the appropriate restriction enzymes (Pharmacia), size separated on a 0.7% agarose gel, and transferred on to Nytran-13N nylon membranes (Schleicher and Schuell, Dassel, Germany) as described. 26 The configuration of the IGK genes was analyzed by means of an ␣ 32 P-dATP randomly labeled IGKDE probe (DAKO Corporation, Carpeteria, CA, USA) in BglII, BamHI/HindIII or HindIII digests (Figure 1a) . 26 The comparative Southern blot analyses at diagnosis and relapse of 10 patients were published previously. 
PCR heteroduplex analysis
PCR amplification was performed as described previously. 28 For the identification of IGK-Kde rearrangements a reverse Kde primer was used in combination with four family-specific primers (VI, VII, VIII, and VIV; the latter cross-hybridizes with VVII) and one J-C intron primer (Figure 2a) . 28 PCR products were examined on a 1% agarose gel. For heteroduplex analysis, positive samples were denatured for 5 min at 94°C and cooled to 4°C for 60 min to induce duplex formation, which were separated in a 6% non-denaturing polyacrylamide gel. 29 For comparative diagnosis-relapse studies, PCR products obtained at diagnosis and at relapse were mixed 1:1 and subjected to heteroduplex analysis. 30 
Sequence analysis
Fluorescent sequencing was performed using the Big Dye-terminator cycle sequencing kit and an ABI 377 automated sequencer (Applied Biosystems, Foster City, CA, USA). Sequence reactions were carried out according to the instructions of the manufacturer. Briefly, 50-200 ng DNA and 3.2 pmol primer were used in a 15 l reaction volume. The cyc-
Figure 2
Schematic representation of an IGK-Kde rearrangement. (a) The position and sequences of the primers used for target identification at diagnosis are indicated. 28 The VIV-5Ј primer crosshybridizes with the VVII gene segment and therefore can also detect VVII-Kde gene rearrangements. 28 (b) Sequences are given of the TaqMan probe and the Kde reverse primer used for RQ-PCR analysis during follow-up of patients. All sequences are given from 5Ј to 3Ј.
ling protocol was 96°C for 30 s, followed by 4 min 60°C for 25 cycles. The template DNA used in the sequence reaction was either the PCR product or a homo-(or hetero-) duplex band excised and eluted from a polyacrylamide gel. The junctional region of each Kde rearrangement was sequenced twice, starting from two independent PCR reactions and from opposite sequence orientations. PCR heteroduplex analysis and sequencing of IGK-Kde gene rearrangements in 21 out of 77 patients at diagnosis have been published previously. 2, 20 Sequences were identified using DNAPLOT software (W Mü ller and H-H Althaus, University of Cologne, Germany) by searching for homology with all known human germline sequences obtained from the VBASE directory of human Ig genes (http://www.mrc cpe.cam.ac.uk/imt-doc/) and IMGT (http://www.imgt.cnusc.fr.8104/). Most sequences were confirmed by using BLAST sequence similarity searching tool (National Center for Biotechnology Information: http://www.ncbi.nlm.nih.gov/BLAST/).
RQ-PCR analysis for MRD detection
All primers and probes were designed as described previously using the Primer Express version 1.0 software (Applied Biosystems) and the OLIGO 6.1 software (W Rychlik, Molecular Biology Insights, Cascade, CO, USA). 21, 22 For the ASO primer approach we designed one germline Kde probe (5Ј-AGC TGC ATT TTT GCC ATA TCC ACT ATT TGG AGT-3Ј) and one germline Kde reverse primer (5Ј-TAC AGA CAG GTC CTC AGA GGT CAG-3Ј) (Figure 2b ). ASO forward primers were designed at the same strand as the germline Kde probes. At least a part of each ASO primer was positioned in the junctional region (Figure 2b ).
RQ-PCR analysis was performed as described previously. 21, 22 To determine the efficiency of amplification and sensitivity of the PCR target, diagnostic DNA was serially diluted into control MNC DNA, from 10 −1 down to 10 −6 . To avoid skewed gene rearrangement patterns and to obtain a bulk of polyclonal control DNA, equivalent mixtures of PB-MNC from 10 different healthy donors were used. The serial dilutions of diagnostic DNA were subjected to RQ-PCR analysis together with negative controls (H 2 O and normal MNC). Serial dilutions of diagnostic samples were analyzed in duplicate, whereas follow-up samples were analyzed in triplicate. To correct for the quantity and quality ('amplifiability') of DNA, we used RQ-PCR analysis of the albumin gene. 21 The reproducible sensitivity of a primers/probe combination was defined as the dilution step with a maximal difference in cycle threshold (C T ) value of 1.5 between the duplicate dilution samples and with a maximal C T value of 40 cycles. The standard curve within this reproducible range should have a correlation coefficient of at least 0.95 for precise quantification. Furthermore, the C T values of the reproducible sensitivity had to be at least three cycles lower than the C T values found with any non-specific amplification in normal MNC DNA. For all experiments, the specificity of amplification and detection was tested on two to six control MNC DNA.
Results
Identification of IGK-Kde rearrangements at diagnosis
The 77 selected precursor-B-ALL patients contained a total of 122 IGK-Kde rearrangements as detected by Southern blot analysis at diagnosis. Twelve of these 122 rearrangements (in six patients; 8%) were derived from subclones, based on band density in Southern blot analysis (Figure 1b) . In four patients with subclones, IGK-Kde rearrangements were also observed in the major clone, whereas in two patients IGK-Kde rearrangements were only observed in the subclone (eg patient 2308 in Figure 1b) 20 The overall mean number of inserted nucleotides in the junctional region was 4.8 (range: 0-30) and the overall mean number of deletions was 9.8 (range: 0-35). Figure 1b) and 20 of the 24 alleles (Table 1 ). For the other six patients (with 11 IGK-Kde rearrangements) no Southern blotting of the relapse sample was carried out, because of insufficient amounts of DNA. To demonstrate that the identified IGK-Kde rearrangements at diagnosis and relapse were identical with respect to their juncLeukemia tional region, mixing experiments of the PCR products at diagnosis and relapse with subsequent denaturation/renaturation were performed for nine patients (Figure 3) , including the six patients without Southern blotting at relapse. In addition, sequence analysis was performed for all 21 patients. These combined experiments showed that 27 of the 32 PCR-detectable IGK-Kde rearrangements indeed had identical sequences Heteroduplex analysis of PCR products of V-Kde and intron-Kde rearrangements present at diagnosis (D) and relapse (R). In addition, mixtures (1:1) of the PCR products from diagnosis and relapse were subjected to heteroduplex analysis (D+R) and loaded onto the polyacrylamide gel. All IGK-Kde-rearrangements appeared to be identical.
Stability of IGK-Kde rearrangements at relapse
at diagnosis and relapse (84%), implying that in 19 of the 21 patients (90%) at least one IGK-Kde rearrangement represented a stable MRD-PCR target (Table 1) .
Changes at relapse were observed in five IGK-Kde rearrangements present in four patients (2308, 4803, 5142, and 5171) ( Table 1 ). In patient 2308 the two subclonal IGKKde rearrangements at diagnosis were replaced by two different IGK-Kde rearrangements at relapse (Figure 1b) . In patient 4803 one of the two major V-Kde rearrangements at diagnosis was replaced by another V-Kde rearrangement at relapse, whereas the second Kde rearrangement persisted at relapse (Figure 1b) . The IGK-Kde rearrangement in the small leukemic subclone in patient 5142 at diagnosis was lost at relapse (Table 1) . Finally, the IGK-Kde rearrangement found in patient 5171 at diagnosis could not be detected by standard PCR/heteroduplex analysis at relapse, but appeared to be detectable by sensitive RQ-PCR analysis (see below); consequently, this target was regarded to be unstable.
In the total group of 21 patients, 84% (27/32) of the IGKKde rearrangements remained stable at relapse, with stability of at least one IGK-Kde rearrangement in 19 of the 21 patients (90%). If the three patients with oligoclonal IGK-Kde rearrangements (patients 2308, 4865, and 5142) were excluded, 25 of the 27 monoclonal IGK-Kde rearrangements (93%) remained stable and at least one stable IGK-Kde rearrangement was found in 17 of the 18 patients (94%).
Applicability of RQ-PCR analysis for MRD detection via IGK-Kde rearrangements
As IGK-Kde rearrangements appeared to be highly stable PCR targets with relatively large junctional regions, we evaluated the applicability of IGK-Kde rearrangements for quantitative MRD detection by RQ-PCR analysis. A germline Kde TaqMan probe and a germline Kde reverse primer were designed as indicated in the Materials and methods section (Figure 2b) . ASO primers were designed at the junctional region of 18 monoclonal IGK-Kde rearrangements (Table 2 ) and tested for their sensitivity, which should reach at least 10 −4 . All PCR were robust, as indicated by a ⌬Rn of 1.0-2.0 for the 10
dilutions and a ⌬Rn of 0.05-1.0 for the 10 −4 dilutions (Figure 4) .
Using the ASO primer approach, sensitivities of р10 −4 were reached at 60°C (the standard temperature) in 15/18 rearrangements (83%) ( Table 2 ). In the RQ-PCR testing of two of these 15 rearrangements (in patients 5162 and 5236), amplification of normal MNC DNA was observed, but the difference in C T values between the specific amplification of the 10 −4 dilution and the nonspecific amplification of normal MNC DNA was Ͼ3 C T . Three of the 18 rearrangements did not fulfill our RQ-PCR requirements after initial testing at 60°C: one rearrangement (in patient 6155) reached a sensitivity of only 10 −3 and RQ-PCR analysis of two rearrangements (in patients 5824 and 6145) resulted in too strong nonspecific amplification of normal MNC DNA (with a C T within three cycles from the C T of the 10 −4 dilution). In the latter two cases, increasing the temperature (to 66°C) resulted in a sensitivity of р10 −4 for one rearrangement, whereas for the other rearrangement a sensitivity of only 10 −3 was reached. Thus, after optimization, 16 of the 18 (89%) IGK-Kde rearrangements reached a sensitivity of р10 −4 , whereas in two of the 18 (11%) IGK-Kde rearrangements a sensitivity of 10 −3 was reached.
Finally, we investigated the use of IGK-Kde rearrangements for the analysis of MRD in follow-up samples of eight children with precursor-B-ALL ( Figure 5 ). All eight patients were treated according to the ALL-8 protocol of the Dutch Childhood Leukemia Study Group. 2 In two patients (5182 and 5397), who remained in CR, MRD levels rapidly dropped to undetectable levels. In two patients (5257 and 5346; Figure 5 ), high levels of MRD (у10 −3 ) remained detectable at early time-points and both patients relapsed. Four patients showed low levels of MRD (Ͻ10 ) at early time-points. Two of these patients remained in CR, whereas the other two patients relapsed 1.3 years (5171) and 4 years (5199) after diagnosis ( Figure 5 ). In patient 5171 the major IGK-Kde rearrangement identified at diagnosis emerged only as a subclone at relapse, implying that the MRD levels at early time-points might have been underestimated.
In six of the eight patients, MRD data obtained by RQ-PCR analysis of the follow-up samples could be compared with MRD data obtained by semi-quantitative dot-plot hybridization. 2, 28 As shown in Figure 5 , both methods gave comparable results.
Discussion
Previous studies have shown that in a random group of precursor-B-ALL patients approximately 50% of cases have one or two IGK-Kde rearrangements. 18, 20, 31 In this study, we evaluated the concordance between Southern blot analysis and PCR/heteroduplex analysis for detection of IGK-Kde rearrangements. 18, 28 Southern blot analysis demonstrated the presence of 110 major IGK-Kde rearrangements in 77 diagnostic samples obtained from precursor-B-ALL patients, selected for the presence of Southern blot-detectable IGK-Kde rearrangements. 18 
Subsequent
PCR/heteroduplex and sequence analysis identified 100 of these major rearrangements, implying that the BIOMED-1 Concerted Action primerset detected 91% of the IGK-Kde rearrangements. The IGKKde rearrangements that could not be identified by our primer 
Figure 4
RQ-PCR analysis of the VII-Kde rearrangement in patient 5199. An ASO primer was designed as shown in Table 2 and Figure 2b . Ten-fold dilutions of the diagnostic sample in normal MNC DNA were analyzed at an annealing temperature of 60°C; a reproducible sensitivity of 10 −4 was reached. Normal MNC DNA did not show amplification in any of the four wells tested.
set may represent rearrangements with V gene segments not recognized by the V family primers (eg VV or VVI), although these V gene segments are rarely used. 20 Alternatively, they may represent unusual IGK-Kde rearrangements, eg rearrangements between Kde and J. 18, 32 Distinction between Ig/TCR gene rearrangements derived from major clones and minor subclones virtually cannot be made by PCR analysis. In contrast, Southern blot analysis can discriminate between major monoclonal and minor subclonal rearrangements based on the relative density of the rearranged Leukemia and/or germline bands. 4, 18 In our series of 77 patients, a total of 12 IGK-Kde subclonal rearrangements were identified by Southern blotting in six patients (8%). This frequency of oligoclonality is substantially lower than found for IGH gene rearrangements, where oligoclonality is observed in 30% to 40% of patients. 4, 8 Detailed data on IGH gene rearrangements was available in 74 out of the 77 selected patients with IGKKde gene rearrangements and showed that virtually all patients also had IGH gene rearrangements. In 29 of these 74 cases (39%) this concerned oligoclonal IGH gene rearrangements, which is the same frequency of IGH oligoclonality as in the total group of precursor-B-ALL. Combined Southern blot and PCR data indicated that monoclonal IGK-Kde gene rearrangements occurred both in patients with monoclonal IGH configuration (43 out of 45; 96%) and oligoclonal IGH configuration (25 out of 29; 86%), with comparable frequencies. Consequently, in the total group of precursor-B-ALL (with IGK-Kde gene rearrangements present in ෂ50% of patients), 18, 19 approximately half of the patients with oligoclonal IGH gene rearrangements should have monoclonal IGK-Kde gene rearrangements available as a PCR target for MRD analysis.
The relatively high frequency of IGK-Kde rearrangements in precursor-B-ALL (ෂ50% of cases) is remarkable, particularly because they frequently occur on both alleles (50 to 60% of involved cases). In mature B cell malignancies, biallelic IGK deletions are only found in Ig-positive cases (ෂ80% of Ig + B cell leukemia), 33 but in precursor-B-ALL the biallelic IGKKde rearrangements do not frequently coincide with IGL gene rearrangements (van der Burg et al, unpublished results). Therefore, it is tempting to speculate that the IGK locus is relatively easily accessible to the recombinase enzyme system in a large fraction of precursor-B-ALL and that the high continuous activity of the recombinase enzyme system pushes the rearrangement process further until the end-stage Kde rearrangements are reached. Consequently, one would expect high frequencies of oligoclonality in IGK gene rearrangements. However, this is found in only a minority (ෂ10%) of cases, whereas the other cases show monoclonal IGK-Kde rearrangements. Apparently, the end-stage IGK-Kde rearrangements are rapidly reached and appear as monoclonal rearrangements at diagnosis in most precursor-B-ALL. Theoretically, this would imply that monoclonal IGK-Kde rearrangements at diagnosis have a high chance of remaining stable during the disease course, whereas subclonal IGK-Kde rearrangements can easily be lost by outgrowth of other subclones with other IGK rearrangements, including other Kde rearrangements. We therefore investigated the stability of IGKKde rearrangements in relation to the monoclonal/subclonal status of these rearrangements.
Comparison between IGK-Kde rearrangements at diagnosis and relapse in 21 patients showed that 27 of the 32 PCRdetectable IGK-Kde rearrangements (84%) remained stable. This high stability of the IGK-Kde rearrangements was based on Southern blot analysis and/or heteroduplex PCR and sequence analysis (Table 1) . When excluding three patients with oligoclonal IGK-Kde rearrangements from the comparative analysis, only two of the 27 major PCR-detectable rearrangements were lost throughout the disease course (7%), implying that at least one stable IGK-Kde rearrangement was found in 17 of the 18 patients with monoclonal IGK-Kde rearrangements (94%). One of the excluded patients (2308) had two subclonal rearrangements, which were both lost during follow-up, while patient (4865) had a single subclonal rearrangement, which remained stable at relapse. Patient 5142 had one major IGK-Kde rearrangement, which remained stable at relapse, and one subclonal IGK-Kde rearrangement, which was lost during follow-up. MRD monitoring in patients with oligoclonal IGK-Kde rearrangements should therefore preferentially focus on other Ig or TCR genes. In a previous study, 11 out of 12 IGK-Kde rearrangements were found to be stable between diagnosis and relapse, 2 which is in agreement with our present results. Our combined data demonstrate that IGK-Kde rearrangements are highly stable and therefore represent excellent PCR targets for the detection of MRD, particularly if oligoclonal targets are excluded.
The number of changes in IGH, TCRD, and TCRG gene rearrangements has been found to correlate with the time span between diagnosis and relapse. 7, 34 The longer the remission duration the higher the chance of secondary or continuing rearrangements. In our study such a correlation could not be made because loss of at least one IGK-Kde rearrangements was observed in only four patients. Technically, V replacements might occur in V-Kde gene rearrangements, comparable to the continuing rearrangements of the IGH gene. 13, 35, 36 However, from a theoretical point of view this is unlikely, because IGK-Kde rearrangements always delete the intronic enhancer (iE in Figure 1a) , thereby most probably preventing ongoing rearrangements in the locus. 37 Our sequence data indeed do not provide evidence for the occurrence of V replacements in the patient group analyzed.
In a previous study, we demonstrated the applicability of the ASO primer approach for sensitive detection of IGH gene rearrangements by RQ-PCR analysis. 22 IGH gene rearrangements have two junctional regions, ie a V H -D H and a D H -J H junction, thereby providing a relatively large sequence that can be considered as a DNA fingerprint of the leukemic cell and thus can be used for the design of an ASO primer. 22, 23 In contrast to IGH gene rearrangements, IGK-Kde rearrangements only have a single junction (intron-Kde or V-Kde) and therefore the possibilities for designing an ASO primer are more limited. Nevertheless, in 16 of the 18 IGK-Kde rearrangements (89%) an ASO primer resulted in a specific amplification with a sensitivity of р10 −4 . Nonspecific amplification of normal MNC DNA was observed in only four cases. In two cases (5162 and 5236) this background amplification occurred at least 3 C T higher than the 10 −4 dilution, and therefore did not need further optimization. In the other two cases, the annealing temperature was increased to reduce the background amplification, which indeed was successful in one case (5824). In the other case (6145), the background could not be sufficiently reduced, resulting in a sensitivity of only 10 −3 . It should be noted that in both cases in which the temperature had to be increased, the last five nucleotides at the 3Ј side of the junctional region contained a GGG-stretch, whereas such a stretch was only found in one of the 16 junctional regions of IGK-Kde rearrangements showing no nonspecific amplification. Therefore, one may consider designing an ASO probe rather than an ASO primer in cases in which a GGG-stretch is present at the 3Ј side of the junctional region.
Alternatively, one might decide to design a germline V or intron RSS probe and primer in combination with a reverse ASO primer. Finally, comparison between MRD data obtained during follow-up by RQ-PCR analysis of IGK-Kde rearrangements were comparable to MRD data obtained by the classical semi-quantitative dot blot hybridization assay using an ASO probe. 2, 28 Comparable results have previously been demonstrated for IGH gene rearrangements. 22 In conclusion, monoclonal IGK-Kde rearrangements are highly stable during the disease course. Because of the high frequency (ෂ50%) of these rearrangements in precursor-B-ALL patients, the high stability at relapse, and the applicability of sensitive RQ-PCR analysis, IGK-Kde rearrangements are excellent PCR targets for clinical MRD studies in precursor-B-ALL patients. So far, only a few MRD studies have used the IGKKde rearrangements, but our data clearly show that they should have a more prominent position in the priority order of MRD-PCR targets.
